Hey Snackers,
Experian is now letting you add monthly Netflix payments to help raise your credit score. Little does Experian know, the password moochers are everywhere. Could this be an elaborate ploy to see if you're still on your ex-boyfriend's cousin's account?
The Nasdaq led the market uptick with some Big Tech gains. In non-stock news: gold prices soared to a record high, and Bitcoin inexplicably surged to break $10K for the 1st time in two months.
Guess we're back to Spelling Bee re-runs... Or Russian ping pong. DraftKings took its fantasy sports app public back in April via SPAC merger (ICYMI: yesterday's SPAC rundown). In May, the sports betting company said it would live-stream sports events through its app. While live sports seemed as far away as an Arby's in a desert, DraftKings stock soared on the hope. Then it soared more when:
What happens in one MLB team... probably doesn't stay in one MLB team. The MLB cancellations made investors realize just how fragile the whole live events situation is... and how quickly it can go south. Investors got hyped on reopenings, then plunged the stock when foreseeable setbacks emerged.
DraftKings occupies a weird spot in the corona-conomy... because its biz is so closely tied to external events. While lockdown couch-boredom would have people flocking to the app for entertainment, the lack of live sports leaves DraftKings powerless. Streamers like Netflix, HBO Max and Hulu will be in the same awkward position if TV/film production doesn't resume soon (although apparently Netflix has content hoarded for years).
Like Viagra in Allbirds packaging... 3-year-old telehealth startup Ro (adorable) just raised a fresh $200M in funding, bringing its valuation to $1.5B (baby Unicorn). Ro started off selling men's hair loss supplements and erectile dysfunction meds. In typical startup fashion, Ro managed to make those things sexy by incorporating three major trends:
Build the brand model, then explode it... Just like Amazon started with books, Ro started with 1 product — now it wants to conquer the digital health industry. Ro's big selling point: it doesn't want your health insurance info in exchange for prescription meds (direct payments only). Since launching men's meds, Ro evolved into a telehealth biz with 4 main verticals:
But can it differentiate enough to disrupt?... Ro has big competition in the "new-age" healthcare space: Walgreens just dropped $1B to add easy-access doctors clinics in-store — it also offers prescription delivery and OTC delivery with Postmates. CVS is opening 1.5K HealthHUB clinics and doing OTC med delivery with DoorDash. TBD whether the 3 major trends Ro latched onto are enough to differentiate. If it's not enough to go mainstream, Ro will have to stay niche.
🍪 Thanks for Snacking with us! Want to share the Snacks? Invite your friends to sign up here.